Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Monkeypox is something ‘everybody should be concerned about’ and ‘would be consequential,’ if it spreads, says President Biden
09:53am, Monday, 23'rd May 2022 MarketWatch
President Biden made remarks about monkeypox, which is contagious and causes a rash akin to chickenpox, to reporters at Osan Air Base in South Korea.
3 Monkeypox Stocks That Soared Last Week
09:13am, Monday, 23'rd May 2022 The Motley Fool
Fear of another viral outbreak is generating a lot of buzz around these three biotech stocks.
The most advanced treatments for monkeypox were developed to address the wrong threat
11:29pm, Friday, 20'th May 2022 Quartz
Monkeypox is treated with smallpox drugs approved in the event of bio-terrorist attacks.
6 Stocks To Watch Amid Monkeypox Outbreak
05:14pm, Friday, 20'th May 2022
A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts. What's going on?
Monkeypox Fears Drive Smallpox Antiviral Makers Higher
12:38pm, Friday, 20'th May 2022 Zacks Investment Research
Emergent BioSolutions (EBS) stock was up almost 12% while SIGA Technologies (SIGA) rose 17.1% on Thursday.
Monkeypox Stocks: SIGA, EBS and TNXP Move Higher on Smallpox Vaccines, Treatments
11:34am, Friday, 20'th May 2022
Monkeypox stocks SIGA, EBS and TNXP are all advancing as fears mount over monkeypox. The disease is related to smallpox.
Monkeypox Fears Drive Smallpox Antiviral Makers Higher
09:47am, Friday, 20'th May 2022
Emergent BioSolutions (EBS) stock was up almost 12% while SIGA Technologies (SIGA) rose 17.1% on Thursday.
Implied Volatility Surging for Emergent Biosolutions (EBS) Stock Options
03:00pm, Thursday, 19'th May 2022 Zacks Investment Research
Investors need to pay close attention to Emergent Biosolutions (EBS) stock based on the movements in the options market lately.
Why Emergent BioSciences Stock Is Soaring Today
02:58pm, Thursday, 19'th May 2022 The Motley Fool
A monkeypox outbreak could boost sales for the company's smallpox vaccine.
Monkeypox Case Reported in U.S. Emergent BioSolutions Makes a Vaccine.
11:33am, Thursday, 19'th May 2022
The ACAM2000 vaccine can be used to prevent the spread of monkeypox, according to the CDC.
Why Emergent BioSciences Stock Is Soaring Today
10:58am, Thursday, 19'th May 2022
A monkeypox outbreak could boost sales for the company's smallpox vaccine.
Chimerix (CMRX) Plunges on Unfavorable Pipeline Updates
01:08pm, Tuesday, 17'th May 2022 Zacks Investment Research
The development of Chimerix's (CMRX) lead candidate, ONC201, gets delayed as the FDA states that data from the retrospective study is unlikely to support an approval. The company ends the DSTAT progra
Here's Why Chimerix Stock Is Imploding Today
02:59pm, Monday, 16'th May 2022 The Motley Fool
Investors are furious about management's plan to sell its most valuable asset in order to chase a lackluster oncology program.
JetBlue Goes Hostile on Spirit, but This Biopharma's Getting Hit Hard
01:11pm, Monday, 16'th May 2022 The Motley Fool
The market looked prepared for a quiet open on Monday.
Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
10:32am, Monday, 16'th May 2022 GlobeNewswire Inc.
GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into a definitive agreement with Chimerix, Inc. (NASDAQ: CMRX), to ac
